首頁 > 市場調查報告書 > 製藥

疫苗

市場調查報告書

商品編碼

2075123

兒童疫苗市場：依疫苗類型、技術、規格、分銷管道和地區分類。

Pediatric Vaccines Market, By Vaccine Type, By Technology, By Type, By Distribution Channel, and By Region

出版日期: 2026年04月28日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，兒童疫苗市場規模將達到552.864億美元，2033年將達到838.466億美元。預計從2026年到2033年，該市場將以6.1%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	552.864億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	6.10%	2033年市場規模預測：	838.466億美元

疫苗接種是一項醫療保健計劃，每十年可預防數千人死亡和數百萬人患病，節省數十億美元。疫苗接種是保護兒童免受疾病侵害（包括癌症、殘疾和死亡）的安全有效途徑。在大流行和其他公共衛生緊急事件中，定期接種疫苗對於防止感染進一步傳播至關重要。針對不同年齡層，有多種疫苗可供選擇，包括成人疫苗和兒童疫苗。兒童疫苗的第一劑在出生時接種。第二劑在6週齡時接種，第三劑在10週齡時接種，最後一劑在14週齡時接種。這種疫苗可以預防脊髓灰質炎，這是一種傳染性極強的疾病，可侵入神經系統並導致癱瘓。

市場動態

預計疫苗法規核准的不斷增加將推動預測期內的市場成長。例如，2022年6月18日，美國疾病管制與預防中心（CDC）批准了適用於6個月及以上嬰兒的新冠疫苗。這使得美國2,000萬5歲以下兒童納入了疫苗接種範圍。目前有兩種疫苗可供5歲以下兒童使用：輝瑞公司的新冠疫苗，需接種三劑，建議6個月至4歲兒童接種3微克劑量；以及莫德納公司的新冠疫苗，需接種兩劑，建議6個月至5歲兒童接種25微克劑量。

主要市場參與者正致力於加強研發活動，利用各種技術生產疫苗對抗包括新冠肺炎在內的感染疾病。例如，2022年6月，跨國製藥和生物技術公司輝瑞和生物技術公司BioNTech SE公佈了評估兩種針對Omicron株的新冠肺炎候選疫苗（一種單價疫苗和一種二價疫苗）的安全性、免疫抗原性和耐受性的積極數據。輝瑞BioNTech的新冠肺炎疫苗與其中一種候選疫苗合併使用，針對Omicron BA.1株的刺突蛋白。二/三期臨床試驗數據顯示，與兩家公司目前提供的新冠疫苗相比，兩種針對Omicron株的候選疫苗的加強劑量均能顯著增強對Omicron BA.1株的免疫反應。這種強烈的免疫反應在30微克和60微克兩種試驗劑量下均有觀察到。輝瑞-BioNTech COVID-19疫苗是基於BioNTech專有的mRNA技術，由BioNTech和輝瑞共同開發。

本研究的主要特點：

本研究確定了各個細分市場的潛在商機，並為該市場說明了一個有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數介紹了全球兒童疫苗市場主要公司的概況：公司概況、產品系列、主要亮點、財務表現和策略。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
全球兒童疫苗市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用全球兒童疫苗市場分析中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第9章競爭情勢

GlaxoSmithKline Plc.
Merck & Co., Inc.
Pfizer Inc.
Sanofi SA
Panacea Biotec
Zydus Cadila
Emergent BioSolutions Inc.
Serum Institute of India Pvt. Ltd.
Bharat Biotech
Indian Immunologicals Ltd.

第10章

調查方法
關於本公司

簡介目錄

Product Code: CMI1708

Pediatric Vaccines Market is estimated to be valued at USD 55,286.4 Mn in 2026 and is expected to reach USD 83,846.6 Mn by 2033, growing at a compound annual growth rate (CAGR) of 6.1% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 55,286.4 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	6.10%	2033 Value Projection:	USD 83,846.6 Mn

Immunizations is one of the public healthcare program for vaccination that prevents thousands of deaths, millions of cases of disease, and saves billions of dollars per decade. Immunizations are a safe, and effective way to protect children from disease including cancers, disability, and death. It is important during a pandemic or other public health emergency to maintain routine immunizations in order to prevent further outbreaks. There are various types of vaccines based on age group that include adult vaccines and pediatric vaccines. The pediatric vaccine is the first dose that is taken at birth. The next dose is taken when the child is 6 weeks old, the third dose at 10 weeks old, and the last dose at 14 weeks old. This vaccine protects against the poliovirus that is a highly infectious disease that invades the nervous system, and can lead to total paralysis.

Market Dynamics

Increasing approval of vaccines by regulatory authorities is expected to drive the market growth over the forecast period. For instance, on June 18, 2022, the Centers for Disease Control and Prevention (CDC) has approved COVID-19 vaccination for young children of age least 6 months old that means 20 million children, in the U.S., that are under 5 years are newly eligible for vaccination. For children under 5, there are two vaccines available. The three-dose Pfizer COVID-19 vaccine is provided to children 6 months to 4 years of age at a 3 microgram dosage. The two-dose Moderna COVID-19 vaccine is recommended for children of age 6 months to 5 years at a dose of 25 micrograms.

Key market players are focusing on increasing research and development activities for producing vaccines that employs various technologies to combat infections such as COVID-19 and others. For instance, in June 2022, Pfizer Inc., a multinational pharmaceutical and biotechnology, and BioNTech SE, a biotechnology company, announced positive data evaluating the safety, immunogenicity, and tolerability, of two Omicron-adapted COVID-19 vaccine candidates: one monovalent and the other bivalent. A combination of the Pfizer-BioNTech COVID-19 Vaccine and a vaccine candidate targets the spike protein of the Omicron BA.1 variant of concern. Data from the Phase 2/3 trial showed that a booster dose of both Omicron-adapted vaccine candidates has substantially higher immune response against Omicron BA.1, as compared to the companies' current COVID-19 vaccine. The robust immune response was seen in two investigational dose levels, 30 µg and 60 µg. The Pfizer-BioNTech COVID-19 Vaccine that is based on BioNTech's proprietary mRNA technology was developed by both BioNTech and Pfizer Inc.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global Pediatric Vaccines Market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study GlaxoSmithKline Plc., Merck & Co., Inc., Pfizer Inc., Sanofi S.A., Panacea Biotec, Zydus Cadila, Emergent BioSolutions Inc., Serum Institute of India Pvt. Ltd., Bharat Biotech, and Indian Immunologicals Ltd.
Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global pediatric vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pediatric vaccines market

Detailed Segmentation:

Global Pediatric Vaccines Market, By Vaccine Type (Revenue, USD Mn, 2021 - 2033)
Pneumococcal Vaccine
DTP Vaccine
Rotavirus Vaccine
MMR Vaccine
Polio Vaccine
Influenza Vaccine
Hepatitis B Vaccine
Meningococcal Vaccine
Hib Vaccine
Varicella Vaccine
Global Pediatric Vaccines Market, By Technology (Revenue, USD Mn, 2021 - 2033)
Live or Attenuated Vaccine
Inactivated or Killed Vaccine
Toxoid Vaccine
Conjugate Vaccine
Subunit Vaccine
Recombinant Vaccine
Global Pediatric Vaccines Market By Type:
Monovalent Vaccine
Multivalent Vaccine
Global Pediatric Vaccines Market By Distribution Channel:
Government
Private
Global Pediatric Vaccines Market, By Region (Revenue, USD Mn, 2021 - 2033)
North America
- By Country:
  - U.S.
  - Canada
Latin America
- By Country:
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- By Country:
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- By Type:
  - By Country
Middle East
- By Country:
  - GCC
  - Israel
  - Rest of Middle East
Africa
- By Country/Region:
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
GlaxoSmithKline Plc.*
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
Merck & Co., Inc.
Pfizer Inc.
Sanofi S.A.
Panacea Biotec
Zydus Cadila
Emergent BioSolutions Inc.
Serum Institute of India Pvt. Ltd.
Bharat Biotech
Indian Immunologicals Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Vaccine Type
- Market Snapshot, By Technology
- Market Snapshot, By Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
Product Launches
Merger, Acquisition, and Collaborations
Regulatory Guideline and Compliances
Key Developments
PEST Analysis
Technology Landscape
PORTER€(TM)s Analysis
Pricing Analysis (2022)

4. Global Pediatric Vaccines Market, By Vaccine Type, 2021€"2033, (US$ Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
Pneumococcal Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
DTP Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
Rotavirus Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
MMR Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
Polio Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
Influenza Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
Hepatitis B Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
Meningococcal Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
Hib Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
Varicella Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)

5. Global Pediatric Vaccines Market, By Technology, 2021€"2033, (US$ Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
Live or Attenuated Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
Inactivated or Killed Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
Toxoid Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
Conjugate Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
Subunit Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
Recombinant Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)

6. Global Pediatric Vaccines Market, By Type, 2021 €" 2033, (US$ Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segments Trends
Monovalent Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
Multivalent Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)

7. Global Pediatric Vaccines Market, By Distribution Channel, 2021 €" 2033, (US$ Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segments Trends
Government
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
Private
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)

8. Global Pediatric Vaccines Market, By Region, 2021 €" 2033, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022€"2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 €" 2033, (US$ Million)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 €" 2033, (US$ Million)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 €" 2033, (US$ Million)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 €" 2033, (US$ Million)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 €" 2033, (US$ Million)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 €" 2033, (US$ Million)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

GlaxoSmithKline Plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Panacea Biotec
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Zydus Cadila
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Emergent BioSolutions Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Serum Institute of India Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bharat Biotech
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Indian Immunologicals Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies